title: Blonanserin ameliorated the tendency toward QTc prolongation associated with risperidone in a patient with schizophrenia.
authors.affiliation: Department of Neuropsychiatry Okayama University Graduate School of Medicine Dentistry, and Pharmaceutical Sciences Okayama, Japan Department of Neuropsychiatry Okayama University Graduate School of Medicine Dentistry, and Pharmaceutical Sciences Okayama, Japan manabuta@cc.okayama-u.ac.jp.
authors.forename: Yutaka
authors.initials: Y
authors.lastname: Mizuki
authors.forename: Manabu
authors.initials: M
authors.lastname: Takaki
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008133:Long QT Syndrome / Q000139:chemically induced* / Q000175:diagnosis*; D010879:Piperazines / Q000627:therapeutic use*; D010880:Piperidines / Q000627:therapeutic use*; D018967:Risperidone / Q000009:adverse effects*; D012559:Schizophrenia / Q000175:diagnosis / Q000188:drug therapy*
chemical_list: D014150:Antipsychotic Agents; D010879:Piperazines; D010880:Piperidines; C079310:blonanserin; D018967:Risperidone